Today: 4 March 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics shares surged nearly 190% to $1.37 on Oct. 17, 2025, after announcing a pharma partnership with Chugai Pharmaceutical worth up to $1.085 billion. The deal includes $10 million upfront, development and sales milestones, and potential royalties. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. Trading volume spiked to several times the daily average.
17 October 2025
···
Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third Bancorp shares rose 2–3% to the low $40s on Oct. 17 after Q3 profit jumped 14% to $608 million, beating analyst estimates. The rebound followed a 4% drop the previous day amid regional bank credit fears. Net interest income climbed 7% to $1.53 billion, helped by easing deposit costs. Earlier this month, Fifth Third announced a $10.9 billion all-stock deal to acquire Comerica.
17 October 2025
····
SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB N.V. shares traded near $33 on Oct. 17, 2025, down over 20% from a year ago despite beating Q3 earnings estimates with $0.69 EPS and $8.93 billion revenue. The company closed a $7.7 billion merger with ChampionX in July, adding $595 million to Q3 revenue. Oil prices fell to $61 Brent, pressuring international revenue, which dropped 7% year-over-year. SLB plans at least $4 billion in shareholder payouts for 2025.
17 October 2025
···
American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express reported record third-quarter revenue of $18.4 billion, up 11% year-over-year, and raised its 2025 outlook after earnings beat estimates at $4.14 per share. Shares hit an all-time high of $349.19 before pulling back to around $330. Affluent cardholder spending rose 12% year-over-year, with no sign of slowdown. Analysts remain broadly positive, with most rating the stock a Buy.
17 October 2025
··
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue shares plunged 13% Thursday to a record low near $14 after news of U.K. lawsuits over Johnson’s Baby Powder, representing 3,000 claimants and potential £1 billion in damages. The stock is down about 34% year-to-date and nearly 40% below its IPO price. Wall Street cut price targets and Moody’s downgraded its outlook to “negative.” Kenvue’s market cap now stands at roughly $30–31 billion.
17 October 2025
···
Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp. shares surged 36% in after-hours trading on Oct. 16 after announcing plans to build or acquire up to 20 cellular towers in Mexico by end-2025. The stock jumped from $2.23 to $2.85 overnight, driven by the company's tiny float of under 730,000 shares. Akanda pivoted to telecom infrastructure after merging with First Towers & Fiber in August 2025. Market cap remains below $2 million.
17 October 2025
·
Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Financial Group shares dropped over 10% on Oct. 16 to $48.80, extending a month-to-date loss of about 25% after revealing $715 million in exposure to bankrupt First Brands Group. Multiple law firms launched probes into possible investor misstatements. Executives insist losses are manageable and called the selloff “overdone.” The decline came as other U.S. banks reported credit issues, fueling sector-wide concerns.
17 October 2025
··
Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green Holdings regained Nasdaq compliance on Oct. 3, 2025, after a 1-for-64 reverse split and restructuring a financing deal. Shares surged 86.7% to $6.03 before retreating to $3. Executives took Q3 pay in stock, and the company is moving operations to a new Texas facility. FY2024 revenue fell to $4.98 million, with a net loss of $16.98 million; market cap stands at $1.5 million.
17 October 2025
···
Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

The average U.S. 30-year fixed mortgage rate fell to 6.27%, its lowest since October 2024, after the Fed’s first rate cut of 2025. Rates remain well above 6%, keeping home sales at a nearly 30-year low despite a small uptick in refinancing. Most forecasts expect rates to stay in the mid-6% range. Buyers are advised not to expect a sharp drop.
17 October 2025
Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Carbon Revolution faces possible Nasdaq delisting after failing equity and filing requirements, with deadlines set for late 2025. CREV shares traded at $3.73 on Oct. 17, 2025, down over 70% from their 52-week high, valuing the company under $7 million. Fiscal 2024 revenue hit a record $47.3 million, but net loss reached $146.4 million. The company warned it needs more funding within a quarter to remain solvent.
17 October 2025
··
Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Over $100 billion in U.S. bank market value was erased Thursday as the Dow fell nearly 400 points and the KBW Regional Banking Index dropped 6%. Zions Bancorp and Western Alliance plunged after disclosing fraud-related loan losses, sparking broad financial sector selloffs. Gold hit a record above $4,370/oz and Treasury yields slid as investors fled to safe havens. Wall Street leaders warned of wider credit risks.
17 October 2025
···
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics shares surged nearly 100% in after-hours trading Oct. 16 after the FDA granted Fast Track status to its AlloNK cell therapy for refractory rheumatoid arthritis. The stock jumped from a $2.77 close to as high as $6.33. Over 20 patients have received AlloNK in trials, with key safety and mechanistic data expected by mid-November. Artiva plans to begin a pivotal Phase 3 trial in 2026, pending results.
17 October 2025
·
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist Financial reported Q3 earnings of $1.04 per share, beating estimates, with net income rising to $1.35 billion on $5.24 billion revenue. Shares jumped 4% after results but remain down 5.3% year-to-date. Fee income surged 11% sequentially, offsetting flat net interest income. The bank maintained its $0.52 dividend and repurchased $500 million in stock.
17 October 2025
···
Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s price has dropped to around $186–$195 after peaking above $250 in early October, testing a key support zone. Nearly $400 million in SOL left exchanges in recent days, signaling heavy profit-taking and reduced liquidity. Andreessen Horowitz invested $50 million in a Solana staking firm, while Forward Industries raised $1.65 billion to buy SOL. Analysts see $186–$195 as critical; failure to hold could send SOL toward $172 or lower.
17 October 2025
·
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi shares surged 230% over the past year, hitting a 52-week high of $30.30 in late September before dropping to $26.60 on Oct. 16. The company will report Q3 earnings on Oct. 28, with analysts expecting EPS of $0.08 on $880 million in revenue. SoFi recently launched fee-free options trading and an AI-focused ETF, and plans to enable crypto payments by late 2025. CEO changes and student loan policy developments are also in focus.
17 October 2025
··
INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility shares jumped nearly 90% to $1.43 on Oct. 16, 2025, with volume topping 108 million amid a sector rally sparked by White House plans to expand IVF access. The stock briefly surpassed $2 before dropping about 30% early the next day as traders took profits. INVO raised $200,000 in a preferred share sale and filed to register 8.35 million shares for resale. The company remains unprofitable and cash-strapped.
17 October 2025
·
Oil Prices Plunge to 5-Month Low as Trump-Putin Summit Looms & India’s Russian Oil U-Turn Rattles Markets

Oil Prices Plunge to 5-Month Low as Trump-Putin Summit Looms & India’s Russian Oil U-Turn Rattles Markets

Brent crude dropped to $60 a barrel, its lowest since May, with U.S. WTI falling below $58 amid a broad market selloff. Oil prices slid further after President Trump and President Putin agreed to meet for Ukraine peace talks. U.S. crude inventories jumped by 3.5 million barrels last week, while output hit a record 13.64 million barrels per day. India plans to gradually cut Russian oil imports by year-end.
17 October 2025
Michigan’s Green Energy Boom: Utilities Hit 50% Renewables Target as Solar Grants Surge

Michigan’s Green Energy Boom: Utilities Hit 50% Renewables Target as Solar Grants Surge

Michigan’s major utilities report they will double renewable energy capacity by 2030, aiming for 50% renewable electricity. DTE and Consumers Energy are investing billions in new solar and wind projects to meet state mandates. State regulators awarded $5 million in grants to 14 local renewable projects this week. Large solar farms are generating millions in tax revenue for rural counties and have created about 20,000 green jobs since 2009.
17 October 2025
····
Femasys (FEMY) Rockets on Fertility Breakthroughs and FDA Milestones – What’s Behind the Surge?

Femasys (FEMY) Rockets on Fertility Breakthroughs and FDA Milestones – What’s Behind the Surge?

Femasys Inc. shares surged 46% intraday on Oct. 16, 2025, closing up 35% at $0.745 amid heavy trading. The rally followed news of regulatory approvals for its FemBloc® birth control system in Europe, UK, and New Zealand, and a major order from a Spanish distributor. The company also announced new partnerships and showcased its fertility treatments at an industry conference. Femasys remains unprofitable but reported 85% year-over-year sales growth in Q2.
17 October 2025
··
1 … 74 75 76 77 78 … 140
Go toTop